Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
09.02.2023 07:36:13
|
Roche, Janssen Biotech To Advance Personalised Healthcare Through Companion Diagnostics
(RTTNews) - Roche (RHHBY) said that it has expanded its collaboration with Janssen Biotech Inc. The New agreement expands activities to include a wide-range of companion diagnostics, including tissue and blood-based biomarkers, sequencing and digital pathology.
The collaboration builds on commitment to personalised healthcare through expanding access of companion diagnostics to enable targeted treatment options for patients, Roche said in a statement.
For More Such Health News, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Rogers Corp.mehr Nachrichten
28.04.25 |
Ausblick: Rogers legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
18.02.25 |
Ausblick: Rogers gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 131,18 | 0,09% |
|
Rogers Corp. | 61,50 | -1,60% |
|